Alex Goldberg

NASDAQ Gainers Watch List: Cisco Systems, Inc. (NASDAQ:CSCO) and NuPathe, Inc. (NASDAQ:PATH) Added to Equity Profile Report's NASDAQ Gainers Watch List.

 
Repost This

Wilmington, DE -- (SBWIRE) -- 12/16/2013 -- Equity Profile Report expands its NASDAQ Gainers Weekly Watch List adding Cisco Systems, Inc. (NASDAQ:CSCO) and NuPathe, Inc. (NASDAQ:PATH).

Cisco Systems, Inc. (NASDAQ:CSCO) a company that designs, manufactures, and sells Internet protocol and other products related to the communications and information technology industry worldwide is currently up (+1.10%) on 12,945,514 shares traded after Cisco Systems Said Services Business Set to Get Boost from SDN. Cisco Systems, Inc. (NASDAQ:CSCO) is currently up (+6.06%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about Cisco Systems, Inc. (NASDAQ:CSCO)

NuPathe, Inc. (NASDAQ:PATH) a specialty pharmaceutical company that focuses on the development and commercialization of branded therapeutics for neurological and psychiatric disorders is currently up (+42.17%) on 5,424,119 shares traded as Endo is to Acquire Specialty Pharmaceutical Company NuPathe. NuPathe, Inc. (NASDAQ:PATH) is currently up (+121.66%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Gainers Watch List.

Click Here to find out what other Investors are saying about NuPathe, Inc. (NASDAQ:PATH)

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:
Equity Profile Report
editor@Equityprofilereport.com